News summary

Comparing plasma p-tau217 and plasma p-tau217/Aβ 42 with CSF biomarkers for assessing Alzheimer’s disease pathology

Source: Nature Aging • Published: 18 Nov 2026, 00:00

Summarized by Masters of Longevity from Nature Aging.

Regulatory-authorized plasma p-tau217 and p-tau217/Aβ42 detected Aβ pathology similarly to CSF.

Comparing plasma p-tau217 and plasma p-tau217/Aβ 42 with CSF biomarkers for assessing Alzheimer’s disease pathology
Key Takeaways
  • Plasma p-tau217 detected amyloid PET positivity with high accuracy.
  • Using one regulatory cutoff, plasma tests matched CSF accuracy.
  • Two-cutoff analyses showed plasma p-tau217 remained comparable to CSF.
Read the full article at Nature Aging ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.